State Of Washington, Resp. v. Alexander Nichelin, App.
Opinion
IN THE COURT OF APPEALS OF THE STATE OF WASHINGTON
STATE OF WASHINGTON, No. 70304-8-1
Respondent, O'J C-> DIVISION ONE
JZ-
v. C_ m cr
UNPUBLISHED OPINION 3C O-r -n
v~
1
ALEXANDER SCOTT NICHELIN, UD —^ "C I^* "v
Xs*
i^p
Appellant. FILED: June 9, 2014 v£>
Trickey, J. — Alexander Nichelin appeals his convictions for identity theft
and possession of stolen property, arguing that the trial court considered
undisclosed information at his drug court termination hearing violating his right to
due process. Because this claim is based on speculation raised for the first time
on appeal, and because the record demonstrates that the trial court relied on
evidence presented at the hearing, we affirm.
FACTS
In July 2011, the State charged Alexander Nichelin with three counts of second degree identity theft and one count of second degree possession of stolen property. On February 29, 2012, Nichelin and the State entered into an Adult Drug Treatment Court (ADTC) agreement. Nichelin agreed to submit the charges to the trial court on a stipulated record for a determination of guilt if he failed to complete the drug court program. The agreement also states:
I agree that any failure in my treatment program, including, but not limited to: positive urinalysis tests, missed tests or out-of-range urine samples, missed treatment, missed court appearances, any failure to abide by the terms of this agreement, or commission of a new crime, may result in modification of the treatment program, revocation of my pre-trial release, or termination from the ADTC.
I must follow the treatment plan as developed by the ADTC Treatment Provider.
I agree to abstain from any use or possession of alcohol, drugs, or drug paraphernalia. If any drugs are prescribed for me by a doctor, I will immediately inform my treatment provider and provide the required documentation.111
Nichelin also signed a statement of ADTC program expectations. He
initialed the following paragraphs:
I am aware that I will be expected to abstain from all use of alcohol and other drugs, except medications prescribed by dentist or doctor. Dentists and doctors must be informed of my drug use history and my participation in Drug Treatment Court. Use of all mind and mood altering medication requires completion of the ADTC Medication Form prior to use. I am aware that all mind and mood altering substances, poppy seeds, medications (such as Nyquil) which contains alcohol and products containing ephedrine (found in sinus and cold allergy meds & an ingredient in amphetamine and methamphetamine) are not to be consumed while in the program. I am aware that I must show any and all prescribed and over-the-counter medications to have approval from the ADTC Team before taking them.
I am aware that I must contact the Drug Court Coordinator or my treatment counselor immediately if I have relapsed. My success in Drug Treatment Court requires me to be honest about any continued use or relapse.[2]
ADTC coordinators also provide program participants with a handbook
directing them to "be very careful not to ingest," among other things, "'[njatural' or
herbal remedies or supplements," "[o]ver the counter or prescription medicines
without prior approval by [a] treatment provider," and "[a]ny mind or mood altering
substances."3 The handbook continues:
1 Clerk's Papers (CP) at 71-72. 2 Exhibit (Ex.) 8. 3 Ex. 6 at 11.
If you receive a positive UA [(urinalysis)] result because you ingested one of the above substances without prior approval, it will be treated as a positive UA and you will be sanctioned.
Read labels and ask questions before you put a substance in your body. Claiming that you did not know what was in something will not be accepted as an excuse. If you receive a positive UA because you used one of the above and failed to follow the directions of your treatment counselor or the ADTC team, you will receive a sanction or be terminated from the program. Be aware of what you are putting into your body. If you have questions, ask your treatment counselor FIRST![4]
In November 2012, a urinalysis test indicated that Nichelin had used
Kratom. The ADTC team decided to terminate Nichelin from the program for (1)
using the substance Kratom, and (2) being dishonest with the team about his use
of Kratom. Nichelin requested an evidentiary hearing before a judge who was
not a member of his ADTC team, according to the provisions of the ADTC
agreement.
At a hearing in March 2013, ADTC coordinator Karla Rasmussen testified that she learns of new drugs and substances through professional conferences
and her contacts with other drug court coordinators and urinalysis specialists.
She testified that "Kratom" is an "addictive" "[m]ind and mood-altering substance"
of which the ADTC team had been aware for two years.5 Rasmussen
acknowledged that Kratom "is currently legal" but claimed "it's on the way to becoming illegal."6 Upon hearing rumors from other program participants that
4 Ex. 6 at 11. 5Verbatim Report of Proceedings (VRP) 3/12/13 at 27-28. 6 VRP 3/12/13 at 55.
No. 70304-8-1/4
Nichelin "was involved with Kratom," Rasmussen asked the urinalysis
department to test him for it.7
According to Rasmussen, when confronted with the positive test, Nichelin
initially said that he had used Kratom six months earlier. After she told him that
the test only detects use within three to five days, Nichelin admitted recent use
and explained that "someone in his doctor's office had recommended Kratom to
him as a sleep aid and that he had been having problems sleeping so he took it
for that."8 Rasmussen also identified letters Nichelin had written to each ADTC
team member apologizing for his dishonesty regarding his use of Kratom.
Rasmussen testified that honesty "is a critical part of the treatment plan,"
and dishonesty "might be the number one reason" participants are terminated.9
She explains to all program participants that there are increasingly serious levels
of dishonesty about continued use or relapse that lead to more serious sanctions.
For example, Rasmussen noted the differing levels of dishonesty between
participants who (1) call the drug coordinator and admit use immediately; (2)
admit use to the technician when providing a sample; (3) admit use after being
confronted with positive test; and (4) deny use after being confronted with a
positive test.10 Rasmussen also testified that in her view, lying about use of mind
or mood-altering substances that "fly underneath drug court's radar" because
testing is new, rare, or expensive, is "really egregious" dishonesty.11
7 VRP 3/12/13 at 28. 8 VRP 3/12/13 at 30. 9 VRP 3/12/13 at 34-36. 10VRP 3/12/13 at 34-35. 11 VRP 3/12/13 at 40-41.
Nichelin presented two witnesses who testified about his progress in
therapy and counseling. Nichelin did not present any evidence or testimony to
contradict Rasmussen's testimony.
During closing argument, defense counsel suggested that "no one really
knows at this point" what Kratom is.12 The following exchange occurred:
THE COURT: Would I have the ability to take judicial notice of what I know of Kratom?
[DEFENSE COUNSEL]: You certainly can. And I don't know how much Mr. Nichelin knew at that time. So, Your Honor, I am asking the Court --
THE COURT: Well, do I have the ability to speculate?
[DEFENSE COUNSEL]: I'd ask the Court not to speculate. And I don't know how much the Court actually does know of Kratom, so I'd ask if the Court does take judicial notice that it only be facts of Kratom itself based on some reliable source.113'
At a hearing two days later, the trial court gave its oral ruling. Without
mentioning the concept of judicial notice or identifying any source of information
outside the record, the trial court found that (1) Kratom is a mood-altering
Free access — add to your briefcase to read the full text and ask questions with AI
State Of Washington, Resp. v. Alexander Nichelin, App. (State Of Washington, Resp. v. Alexander Nichelin, App.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.